Jpmorgan Chase & CO Silo Pharma, Inc. Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Silo Pharma, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 1 shares of SILO stock, worth $1. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1
Previous 1
-0.0%
Holding current value
$1
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding SILO
# of Institutions
11Shares Held
120KCall Options Held
0Put Options Held
0-
Virtu Financial LLC New York, NY41.8KShares$50,2170.0% of portfolio
-
Financial Advocates Investment Management Olympia, WA23.9KShares$28,7250.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.3KShares$19,6000.0% of portfolio
-
Geode Capital Management, LLC Boston, MA16.2KShares$19,4140.0% of portfolio
-
State Street Corp Boston, MA12.5KShares$15,0000.0% of portfolio
About Silo Pharma, Inc.
- Ticker SILO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 3,137,910
- Market Cap $3.77M
- Description
- Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company focuses on merging traditional therapeutics with psychedelic research for patients with depression, post-traumatic stress disorder, Alzheimer's, Parkinson's, and other rare neurological disorders. It has a scientific research agreement with the University ...